Celsius (NASDAQ:CELH – Get Free Report) had its target price reduced by investment analysts at B. Riley from $50.00 to $47.00 in a report released on Monday, Benzinga reports. The firm presently has a “buy” rating on the stock. B. Riley’s price objective indicates a potential upside of 48.12% from the company’s current price. B. Riley also issued estimates for Celsius’ Q3 2024 earnings at $0.02 EPS, FY2024 earnings at $0.65 EPS, FY2025 earnings at $0.71 EPS and FY2026 earnings at $1.09 EPS.
A number of other research analysts have also recently weighed in on CELH. Truist Financial lifted their price objective on Celsius from $30.00 to $35.00 and gave the company a “hold” rating in a research report on Wednesday, October 16th. Jefferies Financial Group lowered their price objective on Celsius from $53.00 to $48.00 and set a “buy” rating on the stock in a research report on Thursday, October 10th. UBS Group lowered their price objective on Celsius from $70.00 to $64.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Piper Sandler lowered their price target on Celsius from $50.00 to $47.00 and set an “overweight” rating on the stock in a report on Tuesday, September 24th. Finally, Stifel Nicolaus lowered their price target on Celsius from $61.00 to $51.00 and set a “buy” rating on the stock in a report on Thursday, September 5th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $56.27.
Check Out Our Latest Analysis on CELH
Celsius Stock Up 2.1 %
Celsius (NASDAQ:CELH – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.05. Celsius had a return on equity of 94.75% and a net margin of 19.58%. The business had revenue of $402.00 million during the quarter, compared to the consensus estimate of $391.07 million. During the same period in the previous year, the company posted $0.17 EPS. The business’s quarterly revenue was up 23.4% compared to the same quarter last year. Research analysts anticipate that Celsius will post 0.79 EPS for the current fiscal year.
Insider Activity
In other Celsius news, CEO John Fieldly sold 74,847 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $32.80, for a total value of $2,454,981.60. Following the transaction, the chief executive officer now owns 1,812,490 shares of the company’s stock, valued at $59,449,672. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 2.20% of the company’s stock.
Hedge Funds Weigh In On Celsius
Hedge funds have recently bought and sold shares of the business. Vontobel Holding Ltd. grew its position in Celsius by 93.5% in the 3rd quarter. Vontobel Holding Ltd. now owns 47,147 shares of the company’s stock valued at $1,479,000 after acquiring an additional 22,786 shares during the last quarter. Lighthouse Investment Partners LLC bought a new position in Celsius in the 2nd quarter valued at $20,024,000. LRI Investments LLC bought a new position in Celsius in the 1st quarter valued at $134,000. Cetera Investment Advisers grew its position in Celsius by 189.3% in the 2nd quarter. Cetera Investment Advisers now owns 186,476 shares of the company’s stock valued at $10,646,000 after acquiring an additional 122,011 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC bought a new position in Celsius in the 1st quarter valued at $563,000. Institutional investors own 60.95% of the company’s stock.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Stories
- Five stocks we like better than Celsius
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Golden Cross Stocks: Pattern, Examples and Charts
- Insider Buying Signals Upside for These 3 Stocks
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.